Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04378959Completed
Randomised, double-blind trial of lidocaine 10% oropharyngeal spray in Cervicalgia (2 arms), sponsored by Johns Hopkins University. Primary endpoint: Mean reduction in average neck pain score on 0-10 numerical rating scale at 4 weeks. Started Feb 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04378959.